Atea Pharmaceuticals
AVIR
AVIR
125 hedge funds and large institutions have $327M invested in Atea Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 126 → 125 (-1)
19% less capital invested
Capital invested by funds: $406M → $327M (-$79.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
125
Holding in Top 10
–
Calls
$13.4M
Puts
$540K
Top Buyers
| 1 | +$2.64M | |
| 2 | +$2.3M | |
| 3 | +$2.05M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.3M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.13M |
Top Sellers
| 1 | -$5.96M | |
| 2 | -$5.69M | |
| 3 | -$1.88M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.34M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$886K |